Matches in SemOpenAlex for { <https://semopenalex.org/work/W2196083955> ?p ?o ?g. }
- W2196083955 endingPage "322" @default.
- W2196083955 startingPage "314" @default.
- W2196083955 abstract "Background The aim was to assess the relationship between treatment efficacy and adverse events (AEs) for patients with advanced renal cell carcinoma treated with first-line sunitinib. Patients and Methods 274 patients were treated with sunitinib (50 mg/d, 4-weeks-on and 2-weeks-off schedule). Physical and laboratory evaluations were done every sixth week. AEs were diagnosed at every visit. Clinical response was assessed every 3 months. The objective response rate (ORR), median progression-free (mPFS) and median overall survival (mOS) and AEs were evaluated. Besides χ2 and log rank tests, multivariate Cox regression analysis and for synergism 1-sided t tests were used. Results The ORR was 25%. After a median follow-up of 32 months, the mPFS and mOS were 9 and 19 months, respectively. Hypertension, diarrhea, hypothyroidism, mucositis, hand-foot syndrome (HFS), skin toxicity, and leukopenia were the most frequent treatment-associated AEs. Significantly longer (P < .01) mPFS and mOS were observed when hypertension, diarrhea, HFS, hypothyroidism, skin toxicity, or leukopenia occurred. A statistically significant synergistic effect of the listed AEs was observed for progression-free survival (P < .001) and overall survival (P < .001). Multivariate analysis revealed that besides the prognostic category, the higher number of AEs (3-6 vs. 0-2) was an independent marker of longer mPFS (24 vs. 5 months, respectively; P < .001) and mOS (51 vs. 9 months, respectively; P < .001). Conclusion Results of this study provide evidence for the synergistically enhanced efficacy of sunitinib treatment in patients who present multiple AEs. These AEs are diagnosed routinely and their coexistence can help physicians to predict which group of patients would benefit the most from first-line sunitinib treatment." @default.
- W2196083955 created "2016-06-24" @default.
- W2196083955 creator A5000876847 @default.
- W2196083955 creator A5007654866 @default.
- W2196083955 creator A5010650581 @default.
- W2196083955 creator A5012548854 @default.
- W2196083955 creator A5046043559 @default.
- W2196083955 creator A5051508644 @default.
- W2196083955 creator A5054493286 @default.
- W2196083955 creator A5064012236 @default.
- W2196083955 creator A5068554206 @default.
- W2196083955 date "2016-08-01" @default.
- W2196083955 modified "2023-09-29" @default.
- W2196083955 title "Synergistic Survival: A New Phenomenon Connected to Adverse Events of First-Line Sunitinib Treatment in Advanced Renal Cell Carcinoma" @default.
- W2196083955 cites W1592861466 @default.
- W2196083955 cites W1933440621 @default.
- W2196083955 cites W1967487178 @default.
- W2196083955 cites W1970255472 @default.
- W2196083955 cites W1976043651 @default.
- W2196083955 cites W1991149945 @default.
- W2196083955 cites W2018683437 @default.
- W2196083955 cites W2024632629 @default.
- W2196083955 cites W2038827789 @default.
- W2196083955 cites W2044186882 @default.
- W2196083955 cites W2048404979 @default.
- W2196083955 cites W2059927424 @default.
- W2196083955 cites W2082126987 @default.
- W2196083955 cites W2092273103 @default.
- W2196083955 cites W2095796938 @default.
- W2196083955 cites W2096093767 @default.
- W2196083955 cites W2099088585 @default.
- W2196083955 cites W2108045918 @default.
- W2196083955 cites W2115966993 @default.
- W2196083955 cites W2119404465 @default.
- W2196083955 cites W2123684576 @default.
- W2196083955 cites W2128129838 @default.
- W2196083955 cites W2128412585 @default.
- W2196083955 cites W2130201137 @default.
- W2196083955 cites W2132979246 @default.
- W2196083955 cites W2149267995 @default.
- W2196083955 cites W2149456801 @default.
- W2196083955 cites W2462198268 @default.
- W2196083955 doi "https://doi.org/10.1016/j.clgc.2015.11.016" @default.
- W2196083955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26774206" @default.
- W2196083955 hasPublicationYear "2016" @default.
- W2196083955 type Work @default.
- W2196083955 sameAs 2196083955 @default.
- W2196083955 citedByCount "11" @default.
- W2196083955 countsByYear W21960839552017 @default.
- W2196083955 countsByYear W21960839552018 @default.
- W2196083955 countsByYear W21960839552019 @default.
- W2196083955 countsByYear W21960839552020 @default.
- W2196083955 countsByYear W21960839552022 @default.
- W2196083955 crossrefType "journal-article" @default.
- W2196083955 hasAuthorship W2196083955A5000876847 @default.
- W2196083955 hasAuthorship W2196083955A5007654866 @default.
- W2196083955 hasAuthorship W2196083955A5010650581 @default.
- W2196083955 hasAuthorship W2196083955A5012548854 @default.
- W2196083955 hasAuthorship W2196083955A5046043559 @default.
- W2196083955 hasAuthorship W2196083955A5051508644 @default.
- W2196083955 hasAuthorship W2196083955A5054493286 @default.
- W2196083955 hasAuthorship W2196083955A5064012236 @default.
- W2196083955 hasAuthorship W2196083955A5068554206 @default.
- W2196083955 hasConcept C126322002 @default.
- W2196083955 hasConcept C197934379 @default.
- W2196083955 hasConcept C2777472916 @default.
- W2196083955 hasConcept C2778496288 @default.
- W2196083955 hasConcept C2778570526 @default.
- W2196083955 hasConcept C2779490328 @default.
- W2196083955 hasConcept C2779802037 @default.
- W2196083955 hasConcept C2780873365 @default.
- W2196083955 hasConcept C29730261 @default.
- W2196083955 hasConcept C38180746 @default.
- W2196083955 hasConcept C50382708 @default.
- W2196083955 hasConcept C71924100 @default.
- W2196083955 hasConcept C90924648 @default.
- W2196083955 hasConceptScore W2196083955C126322002 @default.
- W2196083955 hasConceptScore W2196083955C197934379 @default.
- W2196083955 hasConceptScore W2196083955C2777472916 @default.
- W2196083955 hasConceptScore W2196083955C2778496288 @default.
- W2196083955 hasConceptScore W2196083955C2778570526 @default.
- W2196083955 hasConceptScore W2196083955C2779490328 @default.
- W2196083955 hasConceptScore W2196083955C2779802037 @default.
- W2196083955 hasConceptScore W2196083955C2780873365 @default.
- W2196083955 hasConceptScore W2196083955C29730261 @default.
- W2196083955 hasConceptScore W2196083955C38180746 @default.
- W2196083955 hasConceptScore W2196083955C50382708 @default.
- W2196083955 hasConceptScore W2196083955C71924100 @default.
- W2196083955 hasConceptScore W2196083955C90924648 @default.
- W2196083955 hasIssue "4" @default.
- W2196083955 hasLocation W21960839551 @default.
- W2196083955 hasLocation W21960839552 @default.
- W2196083955 hasOpenAccess W2196083955 @default.
- W2196083955 hasPrimaryLocation W21960839551 @default.
- W2196083955 hasRelatedWork W1992943540 @default.
- W2196083955 hasRelatedWork W2108045918 @default.
- W2196083955 hasRelatedWork W2417130606 @default.
- W2196083955 hasRelatedWork W2468742732 @default.